Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, give a significant warning to public health [1-3]. Despite significant medical researches however, how, when and where new diseases appear are yet an origin of considerable uncertainty [4]. On 31 December 2019, the Wuhan Municipal Health Commission in Wuhan City, Hubei province, China reported a cluster of pneumonia cases with unspecified etiology that had a history of exposure to Wuhan's Huanan Seafood Wholesale Market (a wholesale fish and live animal market selling different animal species). On 9 January 2020, China CDC reported that a novel coronavirus (2019-nCoV) had been detected as the causative agent and the genome sequence was made publicly available. Sequence analysis displayed that the newly-identified virus is belonging to the SARS-CoV clade [5]. In an effort to prevent the prevalence, travel limitations were imposed on Wuhan from 23 January, and have since expanded to 12 other cities, and large social gatherings annulled [6, 7]. The Corona Virus Disease-2019 (COVID-19) pandemic by 2019-nCoV is spreading worldwide, and by March 27, 2020, 199 countries, including Iran, have been affected. According to worldwide statistics, the mortality rate is 3.4%. Early symptoms of COVID-19 involves pneumonia, fever, myalgia and fatigue. To date, no successful vaccine or antiviral agents has been clinically approved for COVID-19. Therefore, prevention and control of infection is the most important priority for the public health [8,9].
During the 2019–20 coronavirus pandemic, Iran reported the first authenticated cases of SARS-CoV-2 infections on 19 February 2020 in Qom.[10] As of 27 March 2020, pursuant to Iranian health authorities, there had been 2378 COVID-19 deaths in Iran with more than 32,000 confirmed infections. Also, in the same date, Iran had the fourth highest in term of the number of COVID-19 deaths after Mainland China , Italy and Spain and the first rank in Western Asia. Accordingly, the mean age and sex ratio (man/female) of patients were 59 years and 1.4 respectively; in Iran. Among the deaths related to SARS-CoV-2, 59% were males and 41% females. In early March 2020, non-Iranian-government sources stated assessment of the numbers of SARS-CoV-2 infections that were much higher than official values [11-15].
There are considerable uncertainties in assessing the risk of this disease, due to lack of detailed epidemiological analyses. Extensive researches into the 2019-nCoV are needed to fully elucidate its pathway and pathogenic mechanisms, and to identify potential therapeutic targets, which can be effective in developing the common preventive and therapeutic measures. The behavior prediction of COVID-19 is an important problem. Therefore, in this research, we compared the different distributions of COVID-19 cases based on the daily reported data.